Michael Cohen

1.0k total citations
45 papers, 789 citations indexed

About

Michael Cohen is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Michael Cohen has authored 45 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Medicine and 7 papers in Infectious Diseases. Recurrent topics in Michael Cohen's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Michael Cohen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Michael Cohen collaborates with scholars based in United States and Australia. Michael Cohen's co-authors include Stanley S. Wallack, Gregory E. Roland, Michael D. Huband, James Barlow, Carl L. Heifetz, John M. Domagala, Mark J. Suto, J. M. DOMAGALA, John P. Miller and Timothy J. Griffin and has published in prestigious journals such as Administrative Science Quarterly, Journal of Clinical Microbiology and Journal of Medicinal Chemistry.

In The Last Decade

Michael Cohen

41 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Cohen United States 17 176 174 136 133 94 45 789
Jessica Cohen United States 22 36 0.2× 344 2.0× 29 0.2× 83 0.6× 126 1.3× 86 2.2k
Guillém López i Casasnovas Spain 16 19 0.1× 486 2.8× 57 0.4× 42 0.3× 70 0.7× 130 1.2k
Jennifer Rubin United States 17 32 0.2× 155 0.9× 30 0.2× 14 0.1× 164 1.7× 54 793
Raquel Ortega Spain 14 41 0.2× 37 0.2× 77 0.6× 48 0.4× 117 1.2× 52 738
Kenneth Coleman United States 15 198 1.1× 74 0.4× 262 1.9× 100 0.8× 237 2.5× 59 868
Sankar Mukhopadhyay United States 14 28 0.2× 70 0.4× 9 0.1× 96 0.7× 92 1.0× 59 815
Jeffrey Williams United States 17 40 0.2× 52 0.3× 20 0.1× 84 0.6× 78 0.8× 58 1.0k
John Gilbert United States 15 23 0.1× 39 0.2× 57 0.4× 12 0.1× 73 0.8× 60 861
James Kirby Martin United States 8 31 0.2× 21 0.1× 73 0.5× 118 0.9× 76 0.8× 43 548
Daniel M. Walker United States 27 34 0.2× 721 4.1× 5 0.0× 222 1.7× 140 1.5× 127 2.0k

Countries citing papers authored by Michael Cohen

Since Specialization
Citations

This map shows the geographic impact of Michael Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cohen more than expected).

Fields of papers citing papers by Michael Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cohen. The network helps show where Michael Cohen may publish in the future.

Co-authorship network of co-authors of Michael Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cohen. A scholar is included among the top collaborators of Michael Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cohen. Michael Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaughan, Josephine, et al.. (2021). Determining and representing value in creative placemaking. Journal of Place Management and Development. 14(4). 430–445. 4 indexed citations
2.
Cohen, Michael. (2019). The Use of Blockchain Technology to Solve Common Challenges in the Supply Chain.
3.
Cohen, Michael, et al.. (2018). Valuing creative place making: development of a toolkit for public and private stakeholders: Stage 1: literature review 2018. Figshare. 1 indexed citations
4.
Shahlaee, Abtin, et al.. (2017). Quality and Utility of a Portable Anterior Segment and Non-mydriatic Fundus Camera Linked to a Smartphone-Based Virtual Consultation Platform. Investigative Ophthalmology & Visual Science. 58(8). 4840–4840. 3 indexed citations
5.
Doty, Pamela, Michael Cohen, John P. Miller, & Xiangdang Shi. (2010). Private Long-term Care Insurance: Value to Claimants and Implications for Long-term Care Financing. The Gerontologist. 50(5). 613–622. 13 indexed citations
6.
Geppert, Cynthia & Michael Cohen. (2006). Consultation-Liaison Psychiatrists on Bioethics Committees: Opportunities for Academic Leadership. Academic Psychiatry. 30(5). 416–421. 6 indexed citations
7.
Cohen, Michael. (2002). Ruly Crew: Lessons from the Clinton Administration's Attempts to Cajole the States into Complying with Federal Mandates for Standards-Based Reform. (Feature). Education next. 2(3). 42. 1 indexed citations
8.
Cohen, Michael, et al.. (2001). Patterns of Informal and Formal Caregiving Among Elders With Private Long-Term Care Insurance. The Gerontologist. 41(2). 180–187. 18 indexed citations
9.
Cohen, Michael & Michael D. Huband. (1999). Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Diagnostic Microbiology and Infectious Disease. 33(1). 43–46. 18 indexed citations
10.
Cohen, Michael. (1998). Emerging Trends in the Finance and Delivery of Long-Term Care: Public and Private Opportunities and Challenges. The Gerontologist. 38(1). 80–89. 16 indexed citations
11.
Cohen, Michael, et al.. (1996). Sparfloxacin worldwide in vitro literature: Isolate data available through 1994. Diagnostic Microbiology and Infectious Disease. 25(2). 53–64. 16 indexed citations
12.
Cohen, Michael, et al.. (1994). In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and β-lactamase stability. Diagnostic Microbiology and Infectious Disease. 18(1). 31–39. 17 indexed citations
13.
Cohen, Michael, et al.. (1994). In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models. Diagnostic Microbiology and Infectious Disease. 18(1). 41–47. 1 indexed citations
14.
Cohen, Michael, Nanda Kumar, & Stanley S. Wallack. (1993). New Perspectives on the Afford ability of Long-term Care Insurance and Potential Market Size. The Gerontologist. 33(1). 105–113. 17 indexed citations
15.
Cohen, Michael, et al.. (1991). In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagnostic Microbiology and Infectious Disease. 14(3). 245–258. 29 indexed citations
16.
Cohen, Michael, et al.. (1991). In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). Diagnostic Microbiology and Infectious Disease. 14(5). 403–415. 12 indexed citations
17.
Cohen, Michael. (1989). Restructuring the system. Society. 26(4). 40–48. 2 indexed citations
18.
Cohen, Michael, et al.. (1988). The Risk Factors of Nursing Home Entry Among Residents of Six Continuingcommunities. Journal of Gerontology. 43(1). S15–S21. 37 indexed citations
19.
Heifetz, Carl L., Paul Bien, Michael Cohen, et al.. (1988). Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates. Journal of Antimicrobial Chemotherapy. 21(suppl B). 29–42. 10 indexed citations
20.
Cohen, Michael, et al.. (1986). Client-Related Risk Factors of Nursing Home Entry Among Elderly Adults. Journal of Gerontology. 41(6). 785–792. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Cohen Breakdown of academic impact, for papers by Guillém López i Casasnovas Breakdown of academic impact, for papers by Jennifer Rubin Breakdown of academic impact, for papers by Raquel Ortega Breakdown of academic impact, for papers by Kenneth Coleman Breakdown of academic impact, for papers by Sankar Mukhopadhyay Breakdown of academic impact, for papers by Jeffrey Williams Breakdown of academic impact, for papers by John Gilbert Breakdown of academic impact, for papers by James Kirby Martin Breakdown of academic impact, for papers by Daniel M. Walker
Rankless by CCL
2026